IP Library Patent Application 11167046
Patent Application
App. No. 11/167,046

Methods for nucleic acid amplification and sequence determination

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/167,046
Abstract

The invention provides methods for sequencing a nucleic acid comprising conducting rolling circle amplification on a circular nucleic acid template, wherein the resulting amplicon is optionally anchored to a substrate in an individually optically resolvable manner, and performing a sequencing reaction.

Claims (21)

1 . A method of determining a sequence of a nucleic acid, the method comprising the steps of:

(a) conducting rolling circle amplification of a nucleic acid to produce an amplicon comprising about two to about one hundred linked complements of a nucleic acid; wherein said amplicon is anchored to a substrate, such that said amplicon is individually optically resolvable; and

(b) determining a sequence of at least a portion of said nucleic acid.

2 . The method of claim 1 , wherein said nucleic acid is genomic DNA, cDNA, or RNA.

3 . The method of claim 1 , wherein said amplification step comprises circularizing said nucleic acid thereby forming a circular template; combining said circular template with a primer, a polymerizing agent, and nucleotides; and producing an amplicon comprising multiple linked complements of said circular template.

4 . The method of claim 3 , wherein said primer binds to at least one of the 3′ end and the 5′ end of the nucleic acid.

5 . The method of claim 1 , wherein said nucleic acid is single stranded.

6 . The method of claim 1 , wherein said nucleic acid is double stranded, and wherein said amplification step further includes the step of denaturing said double stranded nucleic acid prior to combining with said primer.

7 . The method of claim 1 , wherein said amplicon is anchored to said substrate after completion of said amplification step.

8 . The method of claim 1 , wherein said amplicon is covalently bound to said substrate.

9 . The method of claim 1 , wherein said amplicon is anchored to said substrate via a biotin-streptavidin complex.

10 . The method of claim 1 , wherein said amplicon comprises a number of linked complements of the nucleic acid, said number determined by a concentration of nucleotides available for incorporation into said amplicon.

11 . The method of claim 1 , wherein said substrate comprises an accumulation of negative charge.

12 . The method of claim 1 , wherein said substrate comprises a plurality of loci for anchoring said amplicon.

13 . The method of claim 1 , wherein said substrate is selected from the group consisting of glass, fused silica, epoxy, plastic, metal, gel matrix, and composites.

14 . The method of claim 13 , wherein said substrate has a chemically modified surface comprising a polyelectrolyte multilayer.

15 . The method of claim 1 , wherein said determining step comprises exposing said amplicon to a sequencing primer, a polymerizing agent, and at least one nucleotide; allowing incorporation of said nucleotide(s) into a synthesis strand; detecting incorporation of said nucleotide(s); and repeating said determining step at least once, thereby determining said sequence of said nucleic acid.

16 . The method of claim 15 , wherein said determining step results in incorporation of about one or about two nucleotides into said synthesis strand.

17 . The method of claim 15 , wherein said nucleotide is labeled with a fluorescent moiety.

18 . The method of claim 1 , wherein said amplification step is performed with a primer that is anchored to said substrate such that upon completion of said amplification step, said amplicon is anchored to said substrate.

19 . The method of claim 1 , wherein said amplification step is performed with a primer that is not anchored to said substrate such that upon completion of said amplification step, said amplicon is not attached to said substrate.

Assignments (10)
TERMINATION AND RELEASE OF NOTICE OF ATTORNEY'S LIEN Recorded Aug 30, 2018
From: BROWN RUDNICK LLP
To: HELICOS BIOSCIENCES CORPORATION
Reel/Frame 046988/0735 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 030714/0598 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: SEQLL, LLC
Reel/Frame 030714/0633 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: COMPLETE GENOMICS, INC.
Reel/Frame 030714/0686 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: ILLUMINA, INC.
Reel/Frame 030714/0783 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2013
From: HELICOS BIOSCIENCES CORPORATION
To: FLUIDIGM CORPORATION
Reel/Frame 030714/0546 →
NOTICE OF ATTORNEY'S LIEN Recorded Apr 17, 2012
From: HELICOS BIOSCIENCES CORPORATION
To: BROWN RUDNICK LLP
Reel/Frame 028060/0898 →
RELEASE OF SECURITY INTEREST Recorded Jan 18, 2012
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: HELICOS BIOSCIENCES CORPORATION
Reel/Frame 027549/0565 →
SECURITY AGREEMENT Recorded Nov 22, 2010
From: HELICOS BIOSCIENCES CORPORATION
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 025388/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2005
From: LAPIDUS, STANLEY N.; BUZBY, PHILIP R.
To: HELICOS BIOSCIENCES CORPORATION
Reel/Frame 016963/0306 →